Skip to content
DAT Supply Log in
Functional compounds · Gummies

Zeaxanthin

Zeaxanthin is a carotenoid pigment found naturally in the macula of the human eye. It is one of the most familiar and commercially understood gummy actives across EU and US markets for eye health and vision support positioning. Zeaxanthin has no EFSA-authorised health claims under Reg. 432/2012; eye health claims must be supported by co-formulated nutrients such as Vitamin A.

  • eye health
  • vision support
  • antioxidant
Build a formula with this ingredient
Zeaxanthin

At a glance

Definition
Zeaxanthin is a carotenoid pigment found naturally in the macula of the human eye. It is one of the most familiar and commercially understood gummy actives across EU and US markets for eye health and vision support positioning. Zeaxanthin has no EFSA-authorised health claims under Reg. 432/2012; eye health claims must be supported by co-formulated nutrients such as Vitamin A.
Common positionings
  • eye health
  • vision support
  • blue light protection
  • macular health
  • antioxidant protection
Format suitability
Reviewed for gummies and sachets — confirmed per project.
Format & category fit

Where this ingredient fits in the DAT Supply catalogue

Every format chip links through to its manufacturing hub and to the private-label catalogue for that format. The category chip routes to the matching vertical hub on the categories index.

Positioning

What it is

Zeaxanthin is a carotenoid pigment belonging to the xanthophyll family. It is naturally present in the human retina, particularly concentrated in the macula, where it helps filter high-energy blue light and supports normal visual function. Alongside lutein, zeaxanthin is one of the most researched dietary carotenoids for eye health.

Brands use zeaxanthin in gummy formulations to target consumers seeking vision support, blue light protection, and long-term eye health. It is frequently paired with lutein and other antioxidant nutrients to create comprehensive eye health products. Zeaxanthin is heat-stable and compatible with gummy manufacturing processes, making it a practical choice for private-label gummy ranges.

Origin and history

Zeaxanthin is a naturally occurring carotenoid found in green leafy vegetables, corn, egg yolks, and orange-coloured fruits and vegetables. It is also present in the petals of the marigold flower (Tagetes erecta), which is the primary commercial source for dietary supplement production. Marigold extracts have been used for centuries as natural colourants and traditional remedies.

Industrial production of zeaxanthin for supplements involves extraction from marigold petals using solvent or supercritical CO2 methods. The extract is then saponified to release free zeaxanthin, which is stabilised in oil or beadlet form for use in softgels, tablets, and gummies. Synthetic zeaxanthin is also available and chemically identical to the natural form.

Scientific overview

Zeaxanthin is deposited in the macula of the human eye, where it acts as a selective blue light filter and a lipid-soluble antioxidant. It protects retinal cells from oxidative stress induced by light exposure and supports the structural integrity of photoreceptor membranes. The human body cannot synthesise zeaxanthin, so dietary intake or supplementation is required to maintain macular pigment density.

Bioavailability of zeaxanthin is enhanced when consumed with dietary fat. In supplement form, it is typically formulated in oil-based carriers or beadlets to improve absorption. The two primary forms available for manufacturing are natural zeaxanthin (from marigold) and synthetic zeaxanthin, which are chemically identical. Natural zeaxanthin is more commonly used in the supplement industry due to consumer preference for natural-sourced ingredients.

From a manufacturing perspective, zeaxanthin is heat-stable and compatible with gummy production temperatures. It is typically supplied as a beadlet or oil-based form that disperses evenly in the gummy matrix. The cost-per-mg is moderate compared to other carotenoids, making it a cost-effective option for eye health gummies. DAT reviews the optimal form and dosage per project to ensure stability and bioavailability.

Why brands use Zeaxanthin

Zeaxanthin is one of the most familiar and commercially understood gummy actives across EU and US markets for eye health and vision support positioning. Consumer awareness of blue light exposure from digital devices has driven strong demand for eye health supplements, particularly among younger demographics. Co-formulating zeaxanthin with lutein creates a powerful synergistic positioning that resonates with consumers seeking comprehensive eye protection.

From a formulation and manufacturing perspective, zeaxanthin offers several advantages for gummy production. It is heat-stable, has a neutral taste profile, and disperses well in oil-based gummy matrices. The typical dosage range of 2–4 mg per serving is easily achievable in a single gummy piece. DAT reviews the optimal form and dosage per project to ensure stability and bioavailability.

For pack copy, brands should note that zeaxanthin has no EFSA-authorised health claims under Reg. 432/2012. Eye health positioning must be supported by co-formulated nutrients with authorised claims, such as Vitamin A (maintenance of normal vision) or Vitamin C (protection of cells from oxidative stress). DAT reviews claim wording per project to ensure compliance with EU and US regulations. No disease claims, no certification promises, and no guaranteed shelf-life should appear on pack until confirmed per project.

Supported formats

Formats this ingredient is reviewed for

DAT Supply covers gummy, capsule, softgel, tablet, powder, oral strip, liquid drop, shot, jelly and pet formats. The list below reflects every format this ingredient is reviewed for — chips link through to the manufacturing hub for each format. Final compatibility, dose and matrix are confirmed per project.

Formulation notes

Verified formulation reference across the formats this ingredient is reviewed for — the Supported formats section lists every product format this active is approved for, and the per-format Considerations section below covers matrix-specific guidance. Final formulation, dose and on-pack copy are confirmed per project.

Gummy fit
Good
Heat stable
Yes
Soluble in matrix
Yes
Cost tier
Medium

Forms available

  • Zeaxanthin (natural extract from marigold), Zeaxanthin (synthetic)

Dosage reference

Typical brand positioning range is 2–4 mg per serving. EU NRV not established for zeaxanthin. Claim thresholds depend on co-formulated nutrients.

Taste & sensory

Zeaxanthin has a mild, neutral taste profile that blends well into fruit-flavoured gummy bases.

Manufacturing notes

Zeaxanthin is heat-stable and oil-dispersible. For gummy manufacturing, it is typically supplied as a beadlet or oil-based form. DAT reviews the optimal form per project.

Format considerations

Per-format formulation notes

Safe-baseline considerations for each format this ingredient is reviewed for. Final formulation, dose and on-pack copy are confirmed per project.

Gummies

  • Taste masking and aroma load against the cooked-base flavour — confirmed per project.
  • Heat exposure during cooking; coated or encapsulated forms may be required — confirmed per project.
  • Matrix choice (pectin vs gelatin) and its effect on ingredient stability — confirmed per project.
  • Per-gummy dose and serving count needed to hit the label claim — confirmed per project.

Develop in gummies →

Sachets

  • Powder flow and dose accuracy at single-serve sachet weights — confirmed per project.
  • Barrier requirements (oxygen, moisture) for the active — confirmed per project.
  • Reconstitution behaviour when the sachet is dosed into water — confirmed per project.

EU-authorised health claims

EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.

Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.

Zeaxanthin is a permitted food ingredient in the EU. No EFSA-authorised health claims exist for zeaxanthin alone under Reg. 432/2012. Eye health positioning must be supported by co-formulated nutrients with authorised claims. DAT reviews claim wording per project.

Studies & evidence

External peer-reviewed sources and regulatory opinions. Citations only — DAT does not endorse the publishers.

  1. Abdel-Aal el-SM, Akhtar H, Zaheer K, Ali R·Nutrients·2013

  2. Stringham JM, Hammond BR·Journal of Food Science·2010

  3. Hammond BR, Fletcher LM, Elliott JG·Optometry and Vision Science·2011

  4. Krinsky NI, Landrum JT, Bone RA·Annual Review of Nutrition·2003

  5. Johnson EJ·Journal of Nutrition·2002

  6. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS)·EFSA Journal·2011

Synergies & conflicts

Pairs well with

Often co-formulated with lutein for synergistic eye health positioning. Also pairs well with Vitamin A, Vitamin C, Vitamin E, and zinc.

Care when combining with

No known formulation conflicts with common gummy ingredients.

Similar ingredients

Ingredients that frequently sit alongside this one in private-label supplement briefs.

Adjacent reading

Pairings, resource guides and blog notes most often associated with Zeaxanthin on DAT Supply briefs.

Common pairings

Ingredients that frequently co-formulate with Zeaxanthin.

Project handoff

Develop a formula featuring Zeaxanthin

Explore concepts already built around this ingredient, or talk to our team to scope a custom formulation.

Continue exploring

Quick context request

Get manufacturing context

Drop your work email and a member of the DAT team will follow up with the right context for this concept. Project documents, certificates and pricing are released through the project workspace in the DAT portal.

You will receive a short confirmation email. Project documents (specification, batch-specific COA, packaging documents) are released through the project workspace in the DAT portal once a brief is in place.